Efficacy of B cell depletion in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor α agents:: an open-label observational study

被引：20

作者：

Brulhart, L.

Ciurea, A.

Finckh, A.

Notter, A.

Waldburger, J. M.

Kyburz, D.

Gabay, C.

机构：

[1] Univ Hosp Geneva, Div Rheumatol, CH-1211 Geneva 4, Switzerland

[2] Univ Zurich Hosp, Rheumaklin, CH-8091 Zurich, Switzerland

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷 / 09期

关键词：

D O I：

10.1136/ard.2005.051169

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

页码：1255 / 1257

页数：4

共 12 条

[1]

THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].

ARNETT, FC ;

EDWORTHY, SM ;

BLOCH, DA ;

MCSHANE, DJ ;

FRIES, JF ;

COOPER, NS ;

HEALEY, LA ;

KAPLAN, SR ;

LIANG, MH ;

LUTHRA, HS ;

MEDSGER, TA ;

MITCHELL, DM ;

NEUSTADT, DH ;

PINALS, RS ;

SCHALLER, JG ;

SHARP, JT ;

WILDER, RL ;

HUNDER, GG .

ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324

[2]

Cohen SB, 2005, ARTHRITIS RHEUM-US, V52, pS677

[3]

Tumor necrosis factor-α antagonists for the treatment of rheumatic diseases [J].

Criscione, LG ;

St Clair, EW .

CURRENT OPINION IN RHEUMATOLOGY, 2002, 14 (03) :204-211

[4]

Prospects for B-cell-targeted therapy in autoimmune disease [J].

Edwards, JCW ;

Cambridge, G .

RHEUMATOLOGY, 2005, 44 (02) :151-156

[5]

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis [J].

Edwards, JCW ;

Szczepanski, L ;

Szechinski, J ;

Filipowicz-Sosnowska, A ;

Emery, P ;

Close, DR ;

Stevens, RM ;

Shaw, T .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (25) :2572-2581

[6]

Fleischmann RM, 2005, ARTHRITIS RHEUM-US, V52, pS131

[7]

Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria [J].

Fransen, J ;

Creemers, MCW ;

Van Riel, PLCM .

RHEUMATOLOGY, 2004, 43 (10) :1252-1255

[8]

Interaction between synovial inflammatory tissue and bone marrow in rheumatoid arthritis [J].

Jimenez-Boj, E ;

Redlich, K ;

Türk, B ;

Hanslik-Schnabel, B ;

Wanivenhaus, A ;

Chott, A ;

Smolen, JS ;

Schett, G .

JOURNAL OF IMMUNOLOGY, 2005, 175 (04) :2579-2588

[9]

B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience [J].

Shaw, T ;

Quan, J ;

Totoritis, MC .

ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 :55-59

[10]

van Gestel AM, 1998, ARTHRITIS RHEUM-US, V41, P1845, DOI 10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.0.CO

← 1 2 →